Tag: Inflammatory liver disease
A milestone achievement: 3,000 patients have joined the NAFLD BioResource
Promising target for liver disease treatments identified
New inflammatory mechanisms unveiled in the setting of liver disease and liver cancer
For the new Midlands Liver Research Alliance, listening comes first
Levelling-up our understanding of liver disease is the aim of the new Midlands Liver Research Alliance,
Continue readingExaLT trial reaches recruitment milestone
Birmingham Led PSC Study Awarded Vital Research Funding
LifeArc and PSC Support have jointly awarded £898,774 for new research into primary sclerosing cholangitis (PSC),
Continue readingReducing liver transplant waiting lists
The increased need for transplantation is widely recognised, as emphasised by National Health Service Blood and
Continue readingPatients with inflammatory liver disease have new hope
NIHR Birmingham BRC and Midlands and Wales Advanced Therapy Treatment Centres (MW-ATTC) ground-breaking research into immune mediated liver
Continue readingNew partnership aims to identify new disease mechanisms and potential targets for treatment of non-alcoholic fatty liver disease
The University of Birmingham’s Centre for Liver and Gastrointestinal Research and Novo Nordisk have joined forces
Continue reading